Detalhe da pesquisa
1.
Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.
JMIR Cancer
; 10: e46979, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569178
2.
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care.
Cancers (Basel)
; 16(5)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473342
3.
Disabled, invisible and dismissed-The lived experience of fatigue in people with myeloproliferative neoplasms.
Cancer Rep (Hoboken)
; 6(1): e1655, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705529
4.
Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.
EJHaem
; 4(1): 216-220, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819189
5.
Robust SARS-CoV-2 T cell responses with common TCRαß motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.
Cell Rep Med
; 4(4): 101017, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030296
6.
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.
Blood Adv
; 8(6): 1439-1443, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231032